In colon cancer, endometrial cancer and retriperitoneal leiomyosarcoma, elevated CREPT expression is correlated with the poor differentiation, increased invasion and metastasis [6, 16, 17, 18]. Here, RPRD1B is linked to malignant colon neoplasm.